Exchange: OTC·Updated 03:55 PM EST

About RDGL

About

Vivos, Inc. is a radiation oncology medical device company. It is engaged in the development of its yttrium-90 based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. Its product, RadioGel, is an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. The company was founded by James C. Katzaroff on December 23, 1994 and is headquartered in Kennewick, WA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
1

Frequently Asked Questions

Advertisement|Remove ads.